These immune checkpoints, such as PD-L1, block the activation of the immune cells against the tumors and CD8 T cell proliferation is less when they are close or in contact with PD-L1-expressing tumor cells (Le et al., 2015; Marisa et al., 2017). The gene discussed is CD274; the disease is neoplasm.